Can anything be done to slow joint or hearing problems caused by COL11A2 mutations?

Early multidisciplinary care helps. Regular audiology visits allow timely hearing‑aid or cochlear‑implant fitting. Physical therapy, low‑impact exercise, and weight management reduce joint stress. In some cases, orthopedic surgeons may intervene for severe scoliosis or joint degeneration. Anti‑inflammatory medications can relieve pain, but disease‑modifying drugs are not yet available.

Is COL11A2 inherited in an autosomal‑dominant or recessive pattern?

Most pathogenic variants act in an autosomal‑dominant manner, meaning a single altered copy can cause disease. However, rare loss‑of‑function mutations may follow an autosomal‑recessive pattern, requiring two defective copies for symptoms to appear. Genetic counseling is essential to clarify the specific inheritance in your family.

How is a COL11A2 mutation confirmed?

Testing usually starts with a targeted gene panel for skeletal dysplasia or hearing loss, or with whole‑exome sequencing. If a variant is found, Sanger sequencing is performed to verify it and to test family members. Blood or saliva samples are sufficient; no special preparation is needed.

What symptoms should make me suspect a COL11A2‑related disorder?

Typical clues include early‑onset hearing loss, especially high‑frequency loss, joint pain or stiffness, facial dysmorphism (flattened nasal bridge, mid‑face hypoplasia), and early osteoarthritis of weight‑bearing joints. Some individuals also develop spinal disc degeneration or scoliosis.

COL11A2 gene

The COL11A2 gene provides instructions for creating a component of type XI collagen, which is essential for the structure and strength of connective tissues throughout the body.

Normal Function

The COL11A2 gene provides instructions for making a component of type XI collagen called the pro-alpha2(XI) chain. Collagens are molecules that provide structure and strength to the connective tissues that support the body's muscles, joints, organs, and skin. Type XI collagen is normally found in cartilage, a tough but flexible tissue that makes up much of the skeleton during early development. Most cartilage is later converted to bone, except for the cartilage that continues to cover and protect the ends of bones and is present in the nose and external ears. Type XI collagen made with the pro-alpha2(XI) chain is also part of the inner ear and the nucleus pulposus, which is the center portion of the discs between the bones of the spine (vertebrae).

Collagens begin as rope-like procollagen molecules that are each made up of three chains. The pro-alpha2(XI) chain combines with two other collagen chains, pro-alpha1(XI) and pro-alpha1(II), to form a triple-stranded procollagen molecule. Then the ropelike procollagen is processed by enzymes to create mature collagen. Mature collagen molecules arrange themselves into long, thin fibrils that form stable interactions (cross-links) with one another in the spaces between cells (the extracellular matrix). The cross-links result in the formation of very strong type XI collagen fibers.

Type XI collagen also helps maintain the spacing and width (diameter) of another type of collagen molecule, type II collagen. Type II collagen is an important component of mature cartilage. The arrangement and size of type II collagen fibrils is essential for the normal structure of these tissues.

Health Conditions Related to Genetic Changes

Fibrochondrogenesis

At least two mutations in the COL11A2 gene have been identified in people with fibrochondrogenesis type 2, a disorder of bone growth characterized by severe skeletal abnormalities and hearing loss. Infants with fibrochondrogenesis type 2 have a very narrow chest that prevents the lungs from developing normally. Most infants with this condition are stillborn or die shortly after birth from respiratory failure, although some have lived into childhood.

The COL11A2 gene mutations that cause fibrochondrogenesis type 2 lead to the production of an abnormal version of the pro-alpha2(XI) chain. When this abnormal chain is incorporated into collagen molecules, it creates defective type XI collagen. The abnormal collagen weakens connective tissues, impairing the formation of bones throughout the skeleton and causing changes in the inner ear that lead to hearing problems.

Otospondylomegaepiphyseal dysplasia

At least 14 mutations in the COL11A2 gene have been found to cause otospondylomegaepiphyseal dysplasia (OSMED), a disorder characterized by skeletal abnormalities, distinctive facial features, and severe hearing loss. These signs and symptoms are similar to those of Weissenbacher-Zweymüller syndrome and to a form of Stickler syndrome classified as type III. In some cases, it can be difficult to tell these conditions apart. Some researchers believe they represent a single disorder with a range of signs and symptoms.

Most of the reported COL11A2 gene mutations that cause OSMED lead to the production of an abnormally short version of the pro-alpha2(XI) chain that is probably not incorporated into type XI collagen molecules. The defective collagen impairs the normal development of several tissues, including bones and the inner ear.

Nonsyndromic hearing loss

MedlinePlus Genetics provides information about Nonsyndromic hearing loss.

Stickler syndrome

MedlinePlus Genetics provides information about Stickler syndrome.

Weissenbacher-Zweymüller syndrome

At least one mutation in the COL11A2 gene has been associated with Weissenbacher-Zweymüller syndrome, a disorder of bone growth characterized by skeletal abnormalities, hearing loss, and distinctive facial features. These signs and symptoms are similar to those of OSMED and to a form of Stickler syndrome classified as type III.

Like the other mutations that cause OSMED, this mutation leads to defective type XI collagen. The abnormal collagen impairs the normal development of several tissues, including bones and the inner ear.

Other Names for This Gene

collagen type XI alpha 2
collagen, type XI, alpha 2
HKE5
PARP
STL3